Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.
作者信息
Mariotti Jacopo, Fowler Daniel H, Bramanti Stefania, Pavletic Steve Z
机构信息
Bone Marrow Transplantation (BMT) and Cell Therapy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Rapa Therapeutics, Rockville, MD, United States.
出版信息
Front Immunol. 2023 May 15;14:1212756. doi: 10.3389/fimmu.2023.1212756. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.社论：移植物抗宿主病防治的争议与期望：生物学与临床视角
Front Immunol. 2023 May 15;14:1212756. doi: 10.3389/fimmu.2023.1212756. eCollection 2023.
2
Emerging drugs for acute graft-versus-host disease.治疗急性移植物抗宿主病的新型药物
Expert Opin Emerg Drugs. 2009 Jun;14(2):219-32. doi: 10.1517/14728210903018891.
3
Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.中药治疗异基因造血干细胞移植后移植物抗宿主病。
Chin J Integr Med. 2020 May;26(5):324-329. doi: 10.1007/s11655-020-3252-y. Epub 2020 Apr 29.
4
Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后严重急性移植物抗宿主病的免疫抑制治疗。
Transplant Proc. 2002 Nov;34(7):2931-3. doi: 10.1016/s0041-1345(02)03493-0.
5
Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.自体造血干细胞移植后移植物抗宿主病的胃肠道病理学：17 例临床病理研究。
Mod Pathol. 2011 Jan;24(1):117-25. doi: 10.1038/modpathol.2010.163. Epub 2010 Oct 15.
6
Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.硼替佐米预防和治疗异基因造血干细胞移植后的移植物抗宿主病
Exp Hematol. 2016 Sep;44(9):771-777. doi: 10.1016/j.exphem.2016.05.005. Epub 2016 May 17.
7
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.一项比较环孢素/甲氨蝶呤与他克莫司/西罗莫司作为异基因造血干细胞移植后移植物抗宿主病预防措施的前瞻性随机试验。
Haematologica. 2016 Nov;101(11):1417-1425. doi: 10.3324/haematol.2016.149294. Epub 2016 Aug 4.
8
Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplantation for hematologic malignancies.去纤苷联合包括移植后环磷酰胺、低剂量兔抗T淋巴细胞球蛋白和环孢素在内的三联疗法，在预防血液系统恶性肿瘤异基因外周血干细胞移植后的移植物抗宿主病方面是有效的。
Transfus Apher Sci. 2022 Feb;61(1):103367. doi: 10.1016/j.transci.2022.103367. Epub 2022 Jan 24.
9
Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.异基因造血干细胞移植后的移植物抗宿主效应：移植物抗宿主病和移植物抗白血病效应
Curr Opin Immunol. 1996 Oct;8(5):674-80. doi: 10.1016/s0952-7915(96)80085-9.
10
The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.HLA-E基因多态性对HLA-E配型相合的异基因造血干细胞移植后移植物抗宿主病的影响
Iran J Allergy Asthma Immunol. 2012 Mar;11(1):15-21.
引用本文的文献
1
Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study.造血干细胞移植后急性和/或慢性移植物抗宿主病患者肠道微生物组成和多样性的改变：一项前瞻性队列研究。
Int J Mol Sci. 2024 May 26;25(11):5789. doi: 10.3390/ijms25115789.
本文引用的文献
1
Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.闭塞性细支气管炎综合征对贝鲁莫地尔的临床反应：来自 2 项前瞻性试验的联合分析。
Blood Adv. 2022 Dec 27;6(24):6263-6270. doi: 10.1182/bloodadvances.2022008095.
2
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.在异基因外周血造血干细胞移植中，与单纯移植后环磷酰胺相比，加用抗胸腺细胞球蛋白对急性髓系白血病的影响：欧洲血液和骨髓移植学会急性白血病工作组的一项回顾性研究。
Transplant Cell Ther. 2022 Sep;28(9):587.e1-587.e7. doi: 10.1016/j.jtct.2022.06.006. Epub 2022 Jun 14.
3
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.采用幼稚 T 细胞耗竭预防慢性移植物抗宿主病。
J Clin Oncol. 2022 Apr 10;40(11):1174-1185. doi: 10.1200/JCO.21.01755. Epub 2022 Jan 10.
4
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.靶向经典 WNT 信号通路可改善实验性硬皮病样慢性移植物抗宿主病。
Blood. 2021 Apr 29;137(17):2403-2416. doi: 10.1182/blood.2020008720.
5
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.阿巴西普阻断共刺激用于预防急性移植物抗宿主病的 II 期临床试验。
J Clin Oncol. 2021 Jun 10;39(17):1865-1877. doi: 10.1200/JCO.20.01086. Epub 2021 Jan 15.
6
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.芦可替尼-ECP 联合治疗难治性重度慢性移植物抗宿主病。
Bone Marrow Transplant. 2021 Apr;56(4):909-916. doi: 10.1038/s41409-020-01122-8. Epub 2020 Nov 17.
7
Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts.非典型靶器官的急性移植物抗宿主病：在神话与现实之间。
Transplant Cell Ther. 2021 Feb;27(2):115-124. doi: 10.1016/j.bbmt.2020.09.033. Epub 2020 Oct 2.
8
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.芦可替尼治疗糖皮质激素难治性急性移植物抗宿主病。
N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22.
9
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.兔抗胸腺细胞球蛋白/抗淋巴细胞球蛋白在异基因造血干细胞移植后预防移植物抗宿主病中的应用：国际专家小组基于共识的推荐意见。
Bone Marrow Transplant. 2020 Jun;55(6):1093-1102. doi: 10.1038/s41409-020-0792-x. Epub 2020 Jan 22.
10
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.免疫抑制治疗慢性移植物抗宿主病患者的疗效。
Biol Blood Marrow Transplant. 2018 Mar;24(3):555-562. doi: 10.1016/j.bbmt.2017.10.042. Epub 2017 Nov 10.
Zotero 插件